2 completed, 1 terminated, 1 unknown, 1 withdrawn. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 2, Terminated 1, Unknown 1, Withdrawn 1 |
Follow Narcan: new trials by email Literature Review of Narcan trials Research Report on Narcan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Outcomes From Nalmefene Nalmefene Hydrochloride Injection, Naloxone Hydrochloride Injection - Opioid Overdose | Phase 4 | Withdrawn | Purdue Pharma LP | 2023-06-01 | 2023-07-12 | |
| Stress and Opioid Misuse Risk: The Role of Endogenous Opioid and Endocannabinoid Mechanisms Placebo, Oxycodone, Naloxone - Opioid Use Disorder, Back Pain | Phase 4 | Completed | Vanderbilt University Medical Center | 101 | 2022-03-02 | 2026-09-04 |
| Increasing Naloxone Access for Persons Who Use Opioids Opioid Overdose Education with Naloxone Distribution, Opioid Overdose Education - Naloxone | Phase 4 | Completed | University of Alabama at Birmingham | 111 | 2021-07-11 | 2023-10-30 |
| Nasal Naloxone for Narcotic Overdose Intranasal (IN) naloxone, Intravenous (IV) naloxone, Intramuscular (IM) naloxone - Drug Overdose | Phase 4 | Unknown | Judith Feinberg | 236 | 2013-09-01 | 2013-07-31 |
| Enteral Naloxone Versus a Traditional Bowel Regimen for the Prevention of Opioid Induced Constipation in Trauma Patients Naloxone and Docusate - Constipation, Analgesia | Phase 4 | Terminated | CAMC Health System | 3 | 2007-08-01 | 2015-07-29 |
Opiate Overdose (2) · Agnosia (1) · Back Pain (1) · Constipation (1) · Drug Overdose (1) · Opioid-Related Disorders (1)
CAMC Health System (1) · Judith Feinberg (1) · Purdue Pharma LP (1) · University of Alabama at Birmingham (1) · Vanderbilt University Medical Center (1)
United States (4)
Audis Bethea, PharmD, BCPS (1) · Judith Feinberg, MD (1) · Michelle Sisson, MA (1) · Stephen Bruehl, PhD (1)
PMID 37091508, PMID 37336007, PMID 39514898
R01DA050334 (1)